FI954497L - Aktiivista ainetta sisältävä laastari estradiolin vapauttamiseksi ihoon - Google Patents

Aktiivista ainetta sisältävä laastari estradiolin vapauttamiseksi ihoon Download PDF

Info

Publication number
FI954497L
FI954497L FI954497A FI954497A FI954497L FI 954497 L FI954497 L FI 954497L FI 954497 A FI954497 A FI 954497A FI 954497 A FI954497 A FI 954497A FI 954497 L FI954497 L FI 954497L
Authority
FI
Finland
Prior art keywords
skin
active ingredient
ingredient patch
release estradiol
estradiol
Prior art date
Application number
FI954497A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954497A7 (fi
FI954497A0 (fi
Inventor
Teresa Maria Murphy
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI954497A7 publication Critical patent/FI954497A7/fi
Publication of FI954497A0 publication Critical patent/FI954497A0/fi
Publication of FI954497L publication Critical patent/FI954497L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
FI954497A 1993-03-26 1994-03-07 Aktiivista ainetta sisältävä laastari estradiolin vapauttamiseksi ihoon FI954497L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4309830A DE4309830C1 (de) 1993-03-26 1993-03-26 Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
PCT/EP1994/000670 WO1994022481A1 (de) 1993-03-26 1994-03-07 Wirkstoffpflaster für die abgabe von estradiol an die haut

Publications (3)

Publication Number Publication Date
FI954497A7 FI954497A7 (fi) 1995-09-22
FI954497A0 FI954497A0 (fi) 1995-09-22
FI954497L true FI954497L (fi) 1995-09-22

Family

ID=6483909

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954497A FI954497L (fi) 1993-03-26 1994-03-07 Aktiivista ainetta sisältävä laastari estradiolin vapauttamiseksi ihoon

Country Status (23)

Country Link
US (1) US5686098A (cs)
EP (1) EP0689458B1 (cs)
JP (1) JPH08508266A (cs)
KR (1) KR960700754A (cs)
AT (1) ATE173636T1 (cs)
AU (1) AU681383B2 (cs)
CA (1) CA2156746A1 (cs)
CZ (1) CZ287544B6 (cs)
DE (2) DE4309830C1 (cs)
DK (1) DK0689458T3 (cs)
ES (1) ES2127384T3 (cs)
FI (1) FI954497L (cs)
GR (1) GR3029387T3 (cs)
HR (1) HRP940213A2 (cs)
HU (1) HU220861B1 (cs)
IL (1) IL109084A (cs)
NO (1) NO953792L (cs)
NZ (1) NZ262418A (cs)
PL (1) PL173547B1 (cs)
SK (1) SK280246B6 (cs)
WO (1) WO1994022481A1 (cs)
YU (1) YU14394A (cs)
ZA (1) ZA941987B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
FR2749586B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Inc Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19702314C2 (de) * 1997-01-23 2000-12-21 Lohmann Therapie Syst Lts Ablösbare Schutzfolie für wirkstoffhaltige, insbesondere selbstklebende Pflastersysteme
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
FR2789586A1 (fr) * 1999-02-16 2000-08-18 Synthelabo Composition pharmaceutique pour administration transmucosale balanique d'alfuzosine
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
FR2869232B1 (fr) * 2004-04-21 2007-09-21 Gattefosse Sas Soc Par Actions Nouveaux excipients pharmaceutiques ou cosmetiques a base d'acetals cyliques
US20060134188A1 (en) * 2004-12-20 2006-06-22 Hans-Peter Podhaisky Transdermal pharmaceutical preparation with a progesterone A-specific ligand (PRASL) as active ingredient
DE102004062182B4 (de) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
FR2912149B1 (fr) * 2007-02-05 2012-10-12 Rhodia Poliamida E Especialidades Ltda Utilisation de derives de dioxolane dans des systemes de revetement et formulation de systeme de revetement
JP5358574B2 (ja) * 2007-08-17 2013-12-04 アルション セラピューティクス， インコーポレイテッド 高濃度の局所麻酔薬調合物
DE102008059054A1 (de) * 2008-11-26 2010-05-27 Otto Bock Pur Life Science Gmbh Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung
JP5639208B2 (ja) * 2013-02-22 2014-12-10 ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダＲｈｏｄｉａ Ｐｏｌｉａｍｉｄａ Ｅ Ｅｓｐｅｃｉａｌｉｄａｄｅｓ Ｌｔｄａ コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物
JP5576523B2 (ja) * 2013-02-22 2014-08-20 ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダ コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物
WO2022045044A1 (ja) * 2020-08-26 2022-03-03 中国塗料株式会社 低ｖｏｃ塗料組成物、塗膜および塗膜付き基材ならびにこれらの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1385914A (en) * 1971-10-19 1975-03-05 Wigglesworth Ltd Compositions having bactericidal activity
BE795226A (fr) * 1972-02-11 1973-08-09 Syntex Corp Vehicule pour pommade contenant du dimethyl-2,2dioxolane-1,3 methanol-4
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US4906169A (en) * 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
DE58906975D1 (de) * 1988-08-02 1994-03-24 Ciba Geigy Mehrschichtiges Pflaster.
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system

Also Published As

Publication number Publication date
AU6208394A (en) 1994-10-24
HRP940213A2 (en) 1998-02-28
ES2127384T3 (es) 1999-04-16
SK280246B6 (sk) 1999-10-08
YU14394A (sh) 1997-01-08
ZA941987B (en) 1995-04-05
NO953792D0 (no) 1995-09-25
CZ287544B6 (en) 2000-12-13
JPH08508266A (ja) 1996-09-03
KR960700754A (ko) 1996-02-24
WO1994022481A1 (de) 1994-10-13
GR3029387T3 (en) 1999-05-28
SK120695A3 (en) 1997-02-05
PL310555A1 (en) 1995-12-27
FI954497A7 (fi) 1995-09-22
CA2156746A1 (en) 1994-10-13
EP0689458A1 (de) 1996-01-03
HUT73425A (en) 1996-07-29
EP0689458B1 (de) 1998-11-25
FI954497A0 (fi) 1995-09-22
IL109084A0 (en) 1994-06-24
DK0689458T3 (da) 1999-08-09
DE59407345D1 (de) 1999-01-07
HU220861B1 (en) 2002-06-29
DE4309830C1 (de) 1994-05-05
NZ262418A (en) 1996-08-27
IL109084A (en) 1996-12-05
CZ248995A3 (en) 1996-03-13
PL173547B1 (pl) 1998-03-31
ATE173636T1 (de) 1998-12-15
US5686098A (en) 1997-11-11
HU9502794D0 (en) 1995-11-28
AU681383B2 (en) 1997-08-28
NO953792L (no) 1995-09-25

Similar Documents

Publication Publication Date Title
FI954497L (fi) Aktiivista ainetta sisältävä laastari estradiolin vapauttamiseksi ihoon
FI950465L (fi) Läpäisevä laastari lääkityksen antamiseksi ihoon
FI930657A7 (fi) Menetelmä pidennetyn aktiiviaineluovutuksen omaavien annosmuotojen valmistamiseksi
DK1468679T3 (da) Tramadolholdig formulering med styret frigivelse
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
BR9509873A (pt) Formulações parasiticidas adequadas para aplicação dérmica
MX9101787A (es) Formulaciones,metodos y dispositivos anticonceptivos transdermicos
NO942477L (no) Opioide formuleringer med forlenget, regulert frigivelse
FI954990L (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
FI973452L (fi) Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
DE59402194D1 (de) Fungizide Wirkstoffkombinationen
FI954989L (fi) Lääkelaastari
DE59408221D1 (de) Fungizide Wirkstoffkombinationen
IS3878A (is) Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
NO20001375L (no) Legemiddelformulering med kontrollert virkestoffrigivning
HUT71740A (en) 2-fluoroalkyl-substituted benzimidazoles, their preparation and their use as insecticides
ATE237927T1 (de) Pestizidformulierung mit langsamer freisetzung
DE69518193D1 (de) Präparat mit verzörgerter Wirkstoffabgabe
BR9100443A (pt) Dispositivo para aplicar ingrediente ativo em inseto
MX9101081A (es) Compuestos fungicidamente activos y procedimiento para su preparacion
ZA902245B (en) Azolylethylcyclopropanes,the preparation thereof and the use thereof as crop protection agents
FI905815A7 (fi) Kontrolloidusti irtoavia koostumuksia ja käyttö
GB9723179D0 (en) Self-adhesive patch for application to the skin
FI954348A0 (fi) Säädetysti vapauttava alumiinia sisältävä farmaseuttinen valmiste